Return to content in this issue

 

Long-term Remission of Wells Syndrome With Omalizumab

Coattrenec Y1, Ibrahim Yasmine L2, Harr T1, Spoerl D1*, Jandus P1*

1Division of Immunology and Allergology, Department of Internal Medicine, University Hospital and Medical Faculty, Geneva, Switzerland
2Division of Clinical Pathology, University Hospital and Medical Faculty, Geneva, Switzerland
*DS and PJ contributed equally to this work.

J Investig Allergol Clin Immunol 2020; Vol 30(1) : 58-59
doi: 10.18176/jiaci.0436

Key words: Wells syndrome, Eosinophilic cellulitis, Omalizumab, Successful treatment